Senior insider sale
General Counsel at CENTESSA PHARMACEUTICALS PLC — senior position signals high conviction
$1.18M
45.96K shares
What this filing means
HUSSAIN IQBAL J plans to sell 45.96K shares of CENTESSA PHARMACEUTICALS PLC valued at approximately $1.18M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/30/2026ACC: 0001969223-26-000076
Officer· General Counsel
Since May 2021
45.96K
Shares to sell
$1.18M
Approx. market value
39.96K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months4
RSU
NA
2/1/2025
14.52KRSU
NA
12/31/2024
8.48KRSU
NA
9/30/2024
8.48KRSU
NA
6/30/2024
8.48KTotal acquired39.96K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/1/2025 | RSU NA | 14.52K | — |
12/31/2024 | RSU NA | 8.48K | — |
9/30/2024 | RSU NA | 8.48K | — |
6/30/2024 | RSU NA | 8.48K | — |
| Total | 39.96K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
6K
Market value
$165.8K
11/17/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
39.96K
Market value
$1.02M
1/30/2026
Total
Units
45.96K
Value
$1.18M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/17/2025 | 6K | $165.8K | — | Completed |
| Planned — Approximate Date | ||||
1/30/2026 | 39.96K | $1.02M | NASDAQ | Planned |
| Total | 45.96K | $1.18M | ||